Conjunctivitis

By 2030 Conjunctivitis Market Reaches $ 6.85 Billion Mark Conjunctivitis Market (By Type: Bacterial Conjunctivitis, Viral Conjunctivitis, and Allergic Conjunctivitis; By Patients Type: Pediatric and Adults; By Drug Class: Antibiotics, Anti-Histaminic, Decongestant, Steroid Drugs, and Others) - Global Market Size, Share, Growth, Trends Analysis, Regional Outlook and Forecasts 2021 - 2030

Share This Article

The conjunctivitis market is expected to exhibit a CAGR of 3.65% from 2021 to 2030 and is projected to reach US$ 6.85 Billion by 2030, according to a 2021 study by Precedence Research, the Canada based market insight company.

The report contains 150+ pages with detailed analysis. The study provides the overall revenue of the global conjunctivitis market from 2017 to 2030, considering 2020 as the base year and 2030 as the forecast year.

The global conjunctivitis market research report gives a brief summary of definitions, size analysis, and place of production, sales, applications, types, and major players/key vendors of the conjunctivitis industry. The report presents fresh perspectives on opportunities and challenges in a significantly transformed post-COVID-19 marketplace. This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.

Conjunctivitis is a contamination of the conjunctiva, a slim membrane layering the white portion of the sclera, eye, or the internal surface of the lids. Conjunctivitis can be very contagious and expand easily within large collections of people. Occasionally, especially in children, the ailment can affect visualization. In such situations, clinicians need to be knowledgeable immediately for effective and primary treatment.

We customize your report according to your research need. REQUEST CUSTOMIZED COPY OF REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/https://www.precedenceresearch.com/sample/1230

Causes of Conjunctivitis:

  • Bacteria
  • Virus
  • Allergens
  • Irritant such as Chemicals

Type of conjunctivitis:

Based on the different agents leading to conjunctivitis, the condition can be classified into the following types.

Bacterial Conjunctivitis:

When the eye’s ability to resist bacterial infections is compromised, conjunctival infection occurs. This can happen during serious illnesses or in immunocompromised individuals. Bacteria such as Streptococcus pneumoniae, the Moraxella species, the Hemophilus species, and the Staphylococcus species can lead to infection. Bacterial conjunctivitis can be further classified into the following types.

Viral Conjunctivitis:

Viral conjunctivitis is caused by viruses and is found to be associated with upper respiratory tract infections. It is a highly contagious condition that begins in one eye and often spreads to the other. As antibiotics do not cure this type of infection, infected individuals must wait for the condition to ease by itself. Medical attention is essential if the infection lasts for over seven days. Adenoviruses and herpes viruses are commonly associated with viral conjunctivitis.

Allergic conjunctivitis:

The conjunctiva, when exposed to the environment, is often associated with allergic and immune-mediated reactions, which lead to allergic conjunctivitis. In this condition, type 1 hypersensitivity reactions occur when an allergen reacts with IgE antibodies, resulting in mast cell degranulation and release of inflammatory mediators. Allergic conjunctivitis can be further classified into the following types.

Growth Factors:

Factors such as increasing prevalence of conjunctivitis, increasing healthcare expenditure, rising exposure to allergens, highly contagious nature of conjunctivitis are driving the growth of conjunctivitis market. Moreover, Additional features that are expected to fuel this business are integration of latest technologies and growing investment by major players.

Smoking affects the ocular surface, resulting in redness, itchiness, and irritation of the eyes. This can cause atopic keratoconjunctivitis and allergic conjunctivitis due to decreased conjunctival sensitivity. Industrialization, especially the automobile industry, involves high levels of pollutants and chemicals. Exposure to diesel exhausts increases the density of inflammatory cells, such as IL-6 and intercellular adhesion molecule-1, leading to the development of allergic conjunctivitis. This will drive the growth of the conjunctivitis medication market, as more individuals will require treatment.

Report Coverage:

Report Highlights Details
Market Size USD 6.85 billion by 2030
Growth Rate CAGR of 3.65% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Patients, Drug Class, Patients Type
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned Atopix Therapeutics Ltd., Allegran, Ocular Therapeutix, Inc., Santen Pharmaceutical Co. Ltd., Novartis, Boehringer Ingelheim, Pfizer Inc, Allegran, Sun Pharma, Sirion Therapeutics, Inc.

Report Highlights:

  • Among the type segment, allergic conjunctivitis dominated the overall market in 2020. High prevalence of allergic conjunctivitis due to high exposure to allergen is the foremost factors attributing to its large market share.
  • The adults segment accounted for the major share of revenue in the patient type segment with more than 63% share in 2020 due to high incidence of conjunctivitis in adults. Pediatric segment is anticipated to grow at the uppermost CAGR through the forecast duration.
  • Anti-histaminic accounted for the largest revenue in the drug-class segment. Use of anti-histaminic for the management of allergic conjunctivitis is the key reason for high market share. Steroid Drugs segment is expected to grow at the highest growth rate through the estimate duration.
  • Allegran, Pfizer Inc, Atopix Therapeutics Ltd. accounted for a significant share of the global conjunctivitis market.

Regional Analysis:

The report includes information for Asia Pacific, North America, Latin America, Europe, Middle East, and Africa. In 2020, the North America region dominated the worldwide market with a market share of higher than 43%. The U.S. indicated the highest slice in North America principally due to early application of latest technologies. Moreover, availability of latest healthcare infrastructure also supported the high market portion of North America.

Europe was the subsequent significant market chiefly due to presence of skilled physicians. Presence of major companies in the European region is also expected to lift the demand for conjunctivitis in the anticipated time-span. The Asia Pacific region is projected to grow at the highest CAGR of around 5.35% in the estimate period due to increasing healthcare expenditure. Latin America and Middle East and African region will display noticeable growth.

Top Players Contending in the Market:

The key companies are aiming towards advanced innovations and are predictable to dominate the target market. Foremost players inspiring in the global conjunctivitis market are as follows:

  • Atopix Therapeutics Ltd.
  • Allegran
  • Ocular Therapeutix, Inc.
  • Santen Pharmaceutical Co. Ltd.
  • Novartis
  • Boehringer Ingelheim
  • Pfizer Inc
  • Allegran
  • Sun Pharma
  • Sirion Therapeutics, Inc.

Market Segmentation

By Type

  • Bacterial Conjunctivitis
  • Viral Conjunctivitis
  • Allergic Conjunctivitis

By Patients Type

  • Pediatric
  • Adults

By Drug Class

  • Antibiotics
  • Anti-Histaminic
  • Decongestant
  • Steroid Drugs
  • Others

Regional Segmentation

  • North America (U.S. and Canada)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Some of the key highlights covered in the report include:

Market Demand-Supply Analysis – The report covers detailed insights into demand and supply forces prevailing in the global conjunctivitis market. It examines trends and factors influencing demand for conjunctivitis globally and gauges the impact of the same on the production.

Pricing Analysis – The report presents an exclusive pricing analysis. It compares pricing strategies adopted by the leading market players and identifies the most remunerative strategies.

Market Segmentation – The report segments the global market in terms of diverse criteria. It identifies the leading segment within each category and identifies growth drivers and restraints affecting growth across each segment.

Regional Analysis – The report segments the market in terms of North America, Europe, Latin America, Asia Pacific, and Rest of the World in terms of region. It has chapters exclusively dedicated to analyzing growth trends across each region. It identifies growth drivers as well challenges affecting demand for conjunctivitis across the world.

Competitive Analysis – Some of the leading market players are profiled in the report on conjunctivitis. The report offers an estimation of share individually help by the market players and determines the impact of some of their popular strategies.

COVID-19 Impact Analysis – This chapter is exclusively dedicated to gauging how the market has evolved or will develop in the post-pandemic era.

Growth Recommendations – In the end, the report presents valuable recommendations to ready businesses for unforeseen challenges in the near future.

Why should you invest in this report?

If you are aiming to enter the global conjunctivitis market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for conjunctivitis are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Conjunctivitis Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Conjunctivitis Market

5.1. Covid-19: Conjunctivitis Industry Impact
5.2. Conjunctivitis Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Conjunctivitis Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Conjunctivitis Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Conjunctivitis Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increased exposure to chemicals and pollutants
6.1.1.2. Rising awareness of condition
6.1.2. Market Restraints
6.1.2.1. Lack of Self Awareness
6.1.3. Market Opportunities
6.1.3.1. Exploring specific treatment for viral conjunctivitis

Chapter 7. Global Conjunctivitis Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Conjunctivitis Market Revenue by Market Players (2016 -2019)
7.1.1.2. Conjunctivitis Market Revenue Market Share by Market Players (2016 -2019)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Conjunctivitis Market, By Type

8.1. Conjunctivitis Market, by Type, 2017-2030
8.1.1. Bacterial Conjunctivitis
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Viral Conjunctivitis
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Allergic Conjunctivitis
8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Conjunctivitis Market, By Patients Type

9.1. Conjunctivitis Market, by Application, 2017-2030
9.1.1. Pediatric
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Adults
9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Conjunctivitis Market, By Drug Class

10.1. Conjunctivitis Market, by Application, 2017-2030
10.1.1. Antibiotics
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Anti-Histaminic
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Decongestant
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Steroid Drugs
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Conjunctivitis Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Type(2017-2030)
11.1.2. Market Revenue Forecast by Patients Type (2017-2030)
11.1.3. Market Revenue Forecast by Drug Class (2017-2030)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2017-2030)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2017-2030)
11.2. Europe
11.2.1. Market Revenue Forecast by Type (2017-2030)
11.2.2. Market Revenue Forecast by Patients Type (2017-2030)
11.2.3. Market Revenue Forecast by Drug Class (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2017-2030)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2017-2030)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Type (2017-2030)
11.3.2. Market Revenue Forecast by Patients Type (2017-2030)
11.3.3. Market Revenue Forecast by Drug Class (2017-2030)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2017-2030)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2017-2030)
11.4. LATAM
11.4.1. Market Revenue Forecast by Type (2017-2030)
11.4.2. Market Revenue Forecast by Patients Type (2017-2030)
11.4.3. Market Revenue Forecast by Drug Class (2017-2030)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2017-2030)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2017-2030)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Type (2017-2030)
11.5.2. Market Revenue Forecast by Patients Type (2017-2030)
11.5.3. Market Revenue Forecast by Drug Class (2017-2030)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2017-2030)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2017-2030)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2017-2030)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2017-2030)

Chapter 12. Company Profiles

12.1. Atopix Therapeutics Ltd.
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Product Portfolio Analysis
12.1.2.1. Type Details, Specification, Application
12.1.3. Revenue, Price, and Gross Margin (2016 – 2019)
12.1.4. Recent Developments and Strategies
12.2. Allegran
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Product Portfolio Analysis
12.2.2.1. Type Details, Specification, Application
12.2.3. Revenue, Price, and Gross Margin (2016 – 2019)
12.2.4. Recent Developments and Strategies
12.3. Ocular Therapeutix, Inc.
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Product Portfolio Analysis
12.3.2.1. Type Details, Specification, Application
12.3.3. Revenue, Price, and Gross Margin (2016 – 2019)
12.3.4. Recent Developments and Strategies
12.4. Santen Pharmaceutical Co. Ltd.
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Product Portfolio Analysis
12.4.2.1. Type Details, Specification, Application
12.4.3. Revenue, Price, and Gross Margin (2016 – 2019)
12.4.4. Recent Developments and Strategies
12.5. Novartis
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Product Portfolio Analysis
12.5.2.1. Type Details, Specification, Application
12.5.3. Revenue, Price, and Gross Margin (2016 – 2019)
12.5.4. Recent Developments and Strategies
12.6. Boehringer Ingelheim
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Product Portfolio Analysis
12.6.2.1. Type Details, Specification, Application
12.6.3. Revenue, Price, and Gross Margin (2016 – 2019)
12.6.4. Recent Developments and Strategies
12.7. Boehringer Ingelheim
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Product Portfolio Analysis
12.7.2.1. Type Details, Specification, Application
12.7.3. Revenue, Price, and Gross Margin (2016 – 2019)
12.7.4. Recent Developments and Strategies
12.8. Sun Pharma
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Product Portfolio Analysis
12.8.2.1. Type Details, Specification, Application
12.8.3. Revenue, Price, and Gross Margin (2016 – 2019)
12.8.4. Recent Developments and Strategies
12.9. Sirion Therapeutics, Inc.
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Product Portfolio Analysis
12.9.2.1. Type Details, Specification, Application
12.9.3. Revenue, Price, and Gross Margin (2016 – 2019)
12.9.4. Recent Developments and Strategies
12.10. Company 10
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Product Portfolio Analysis
12.10.2.1. Type Details, Specification, Application
12.10.3. Revenue, Price, and Gross Margin (2016 – 2019)
12.10.4. Recent Developments and Strategies

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

Purchase This Premium Research Report @ https://www.precedenceresearch.com/checkout/1230

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defence, among different ventures, present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Follow us on LinkedIn | Twitter | Facebook

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →